LPM6690176 / Luye Group - LARVOL DELTA

LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation (clinicaltrials.gov) - P1/2 | N=99 | Not yet recruiting | Sponsor: Luye Pharma Group Ltd.

New P1/2 trial • Colorectal Cancer • Oncology • Solid Tumor

First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors. (clinicaltrials.gov) - P1 | N=102 | Recruiting | Sponsor: Luye Pharma Group Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Metastases • Oncology • Solid Tumor

First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors. (clinicaltrials.gov) - P1 | N=102 | Not yet recruiting | Sponsor: Luye Pharma Group Ltd.

New P1 trial • Oncology • Solid Tumor